Unit
Brustzentrum St.Gallen
BZ · Dept. IV
Letrozole as adjuvant endocrine therapy in postmenopausal women with breast cancer
Köberle D, Thürlimann B. Letrozole as adjuvant endocrine therapy in postmenopausal women with breast cancer. Expert review of anticancer therapy 2006; 6:5-10.
Jan 1, 2006Letrozole as adjuvant endocrine therapy in postmenopausal women with breast cancer
Jan 1, 2006Expert review of anticancer therapy 2006; 6:5-10
Köberle Dieter, Thürlimann Beat
Übersicht Bisphosphonate
Maschke U, Kränzlin M, Krapf R, Pecherstorfer M, Strebel U, Thürlimann B. Übersicht Bisphosphonate. Pharmakritik 2006; 28:17-20.
Jan 1, 2006Übersicht Bisphosphonate
Jan 1, 2006Pharmakritik 2006; 28:17-20
Maschke U.P., Kränzlin M, Krapf R, Pecherstorfer M, Strebel U, Thürlimann Beat
Aromatasehemmer in der modernen Brustkrebstheraphie
Thürlimann B. Aromatasehemmer in der modernen Brustkrebstheraphie. Bulletin Leben wie zuvor 2006; 66:19-22.
Jan 1, 2006Aromatasehemmer in der modernen Brustkrebstheraphie
Jan 1, 2006Bulletin Leben wie zuvor 2006; 66:19-22
Thürlimann Beat
Stimulation of erythrocyte phosphatidylserine exposure by paclitaxel
Lang P, Lang F, Gulbins E, Klarl B, Eisele K, Dreischer P, Niemoeller O, Akel A, Sobiesiak M, Kempe D, Bachmann C, Huober J, Wieder T. Stimulation of erythrocyte phosphatidylserine exposure by paclitaxel. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2006; 18:151-64.
Jan 1, 2006Stimulation of erythrocyte phosphatidylserine exposure by paclitaxel
Jan 1, 2006Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2006; 18:151-64
Lang Philipp A, Lang Florian, Gulbins Erich, Klarl Barbara A, Eisele Kerstin, Dreischer Peter, Niemoeller Olivier M, Akel Ahmad, Sobiesiak Malgorzata, Kempe Daniela S, Bachmann Cornelia, Huober Jens, Wieder Thomas
Vergleich von Docetaxel mit Paclitaxel beim metastasierenden Mammakarzinom
Huober J. Vergleich von Docetaxel mit Paclitaxel beim metastasierenden Mammakarzinom. Geburtsh Frauenheilk 2006; 66:87-89.
Jan 1, 2006Vergleich von Docetaxel mit Paclitaxel beim metastasierenden Mammakarzinom
Jan 1, 2006Geburtsh Frauenheilk 2006; 66:87-89
Huober Jens
Endocrine treatment of metastastic breast cancer
Gerber B, Huober J. Endocrine treatment of metastastic breast cancer. Breast Care 2006; 1:248-251.
Jan 1, 2006Endocrine treatment of metastastic breast cancer
Jan 1, 2006Breast Care 2006; 1:248-251
Gerber B, Huober Jens
Metastastic breast cancer - highlights at ASCO 2006
Huober J. Metastastic breast cancer - highlights at ASCO 2006. Breast Care 2006; 1:270-273.
Jan 1, 2006Metastastic breast cancer - highlights at ASCO 2006
Jan 1, 2006Breast Care 2006; 1:270-273
Huober Jens
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer
Breast International Group (BIG) 1-98 Collaborative Group, Price K, Wardly A, Wardley A, Smith I, Rabaglio M, Gelber R, Castiglione-Gertsch M, Paridaens R, Forbes J, Mauriac L, Mouridsen H, Coates A, Keshaviah A, Thürlimann B, Goldhirsch A. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. NEJM 2005; 353:2747-57.
Dec 29, 2005A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer
Dec 29, 2005NEJM 2005; 353:2747-57
Breast International Group (BIG) 1-98 Collaborative Group, Price Karen N, Wardly Andrew, Wardley Andrew, Smith Ian, Rabaglio Manuela, Gelber Richard D, Castiglione-Gertsch Monica, Paridaens Robert, Forbes John F, Mauriac Louis, Mouridsen Henning, Coates Alan S, Keshaviah Aparna, Thürlimann Beat, Goldhirsch Aron
Adjuvant endocrine therapy in postmenopausal breast cancer patients
Köberle D, Thürlimann B. Adjuvant endocrine therapy in postmenopausal breast cancer patients. Breast (Edinburgh, Scotland) 2005; 14:446-51.
Dec 1, 2005Adjuvant endocrine therapy in postmenopausal breast cancer patients
Dec 1, 2005Breast (Edinburgh, Scotland) 2005; 14:446-51
Köberle Dieter, Thürlimann Beat
Is there really enough evidence to abandon surgery after radiation chemotherapy in esophageal cancer?
Ruhstaller T, Mueller A, Koeberle D, Thuerlimann B. Is there really enough evidence to abandon surgery after radiation chemotherapy in esophageal cancer?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005; 23:8547-8.
Nov 20, 2005Is there really enough evidence to abandon surgery after radiation chemotherapy in esophageal cancer?
Nov 20, 2005Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005; 23:8547-8
Ruhstaller Thomas, Mueller Andreas, Koeberle Dieter, Thuerlimann Beat
Non-enrolment of ovarian cancer patients in clinical trials: reasons and background
Harter P, Staehle A, Huober J, Schmalfeldt B, Gropp M, Wollschlaeger K, Burges A, Schade-Brittinger C, du Bois A, Pfisterer J. Non-enrolment of ovarian cancer patients in clinical trials: reasons and background. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005; 16:1801-5.
Nov 1, 2005Non-enrolment of ovarian cancer patients in clinical trials: reasons and background
Nov 1, 2005Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005; 16:1801-5
Harter P, Staehle A, Huober Jens, Schmalfeldt B, Gropp M, Wollschlaeger K, Burges A, Schade-Brittinger C, du Bois A, Pfisterer J
Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VI
Gruber G, Goldhirsch A, Coates A, Gelber R, Fey M, Simoncini E, Thürlimann B, Carbone A, Crivellari D, Collins J, Golouh R, Lindtner J, Holmberg S, Rudenstam C, Castiglione-Gertsch M, Price K, Nasi M, Bonetti M, International Breast Cancer Study Group. Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VI. JCO 2005; 23:7089-97.
Oct 1, 2005Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VI
Oct 1, 2005JCO 2005; 23:7089-97
Gruber Günther, Goldhirsch Aron, Coates Alan S, Gelber Richard D, Fey Martin F, Simoncini Edda, Thürlimann Beat, Carbone Antonino, Crivellari Diana, Collins John, Golouh Rastko, Lindtner Jurij, Holmberg Stig B, Rudenstam Carl-Magnus, Castiglione-Gertsch Monica, Price Karen N, Nasi M Laura, Bonetti Marco, International Breast Cancer Study Group
Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005
Goldhirsch A, Glick J, Gelber R, Coates A, Thürlimann B, Senn H, Panel members. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 2005; 16:1569-83.
Oct 1, 2005Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005
Oct 1, 2005Ann Oncol 2005; 16:1569-83
Goldhirsch A, Glick J H, Gelber R D, Coates A S, Thürlimann Beat, Senn H-J, Panel members
Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancer
Pagani O, Longhi S, Ruggeri M, Graffeo R, Hess D, Thürlimann B, Lombardi D, Crivellari D, Munzone E, Nolé F, Sessa C, Goldhirsch A. Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancer. Ann Oncol 2005; 16:1609-17.
Oct 1, 2005Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancer
Oct 1, 2005Ann Oncol 2005; 16:1609-17
Pagani O, Longhi S, Ruggeri M, Graffeo R, Hess D, Thürlimann Beat, Lombardi D, Crivellari D, Munzone E, Nolé F, Sessa C, Goldhirsch A
[Mesenteric inflammatory veno-occlusive disease (MIVOD)--a rare cause of intestinal ischemia]
Knauer M, Haid A, Gruber-Mösenbacher U, Wenzl E. [Mesenteric inflammatory veno-occlusive disease (MIVOD)--a rare cause of intestinal ischemia]. Wien Klin Wochenschr 2005; 117:610-4.
Sep 1, 2005[Mesenteric inflammatory veno-occlusive disease (MIVOD)--a rare cause of intestinal ischemia]
Sep 1, 2005Wien Klin Wochenschr 2005; 117:610-4
Knauer Michael, Haid Anton, Gruber-Mösenbacher Ulrike, Wenzl Etienne
[Consensus Meeting of the 9th International Conference on Primary Therapy of Early Breast Cancer (St. Gall, January 26-29, 2005)]
Thürlimann B, Senn H. [Consensus Meeting of the 9th International Conference on Primary Therapy of Early Breast Cancer (St. Gall, January 26-29, 2005)]. Gynäkologisch-geburtshilfliche Rundschau 2005; 45:143-6.
Jun 1, 2005[Consensus Meeting of the 9th International Conference on Primary Therapy of Early Breast Cancer (St. Gall, January 26-29, 2005)]
Jun 1, 2005Gynäkologisch-geburtshilfliche Rundschau 2005; 45:143-6
Thürlimann Beat, Senn H J
Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study
Seium Y, Morant R, Bauer J, Trembleau C, Allal A, Philippe M, Mentha G, Gervaz P, Ruhstaller T, Stupp R, Roth A. Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005; 16:762-6.
May 1, 2005Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study
May 1, 2005Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005; 16:762-6
Seium Y, Morant R, Bauer J, Trembleau C, Allal A, Philippe M, Mentha G, Gervaz P, Ruhstaller Thomas, Stupp R, Roth A D
Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor
Colleoni M, Veronesi A, Holmberg S, Erzen D, Forbes J, Murray E, Thürlimann B, Simoncini E, Pagani O, Collins J, Crivellari D, Rudenstam C, Lindtner J, Price K, Castiglione-Gertsch M, Coates A, Gelber R, Li S, Goldhirsch A. Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor. Ann Oncol 2005; 16:716-25.
May 1, 2005Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor
May 1, 2005Ann Oncol 2005; 16:716-25
Colleoni M, Veronesi A, Holmberg S, Erzen D, Forbes J, Murray E, Thürlimann Beat, Simoncini E, Pagani O, Collins J, Crivellari D, Rudenstam C-M, Lindtner J, Price K N, Castiglione-Gertsch M, Coates A S, Gelber R D, Li S, Goldhirsch A
Undifferentiated sarcoma arising in the brain, 23 years after curative treatment of an ependymoma.
Hofer S, Seeger H, Rordorf T, Knuth A, Janzer R. Undifferentiated sarcoma arising in the brain, 23 years after curative treatment of an ependymoma. J Neurooncol 2005; 72:239.
May 1, 2005Undifferentiated sarcoma arising in the brain, 23 years after curative treatment of an ependymoma.
May 1, 2005J Neurooncol 2005; 72:239
Hofer Silvia, Seeger Harald, Rordorf Tamara, Knuth Alexander, Janzer Robert
Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience
Colleoni M, Thürlimann B, Crivellari D, Murray E, Mendiola C, Pagani O, Castiglione-Gertsch M, Coates A, Price K, Fey M, Collins J, Zahrieh D, Gelber R, Holmberg S, Mattsson J, Rudenstam C, Lindtner J, Erzen D, Snyder R, Goldhirsch A. Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience. JCO 2005; 23:1390-400.
Mar 1, 2005Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience
Mar 1, 2005JCO 2005; 23:1390-400
Colleoni Marco, Thürlimann Beat, Crivellari Diana, Murray Elizabeth, Mendiola Caesar, Pagani Olivia, Castiglione-Gertsch Monica, Coates Alan S, Price Karen, Fey Martin F, Collins John, Zahrieh David, Gelber Richard D, Holmberg Stig B, Mattsson Jan E, Rudenstam Carl-Magnus, Lindtner Jurij, Erzen Darja, Snyder Raymond, Goldhirsch Aron